Skip to content

Debt-to-assets at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.1×0.0×
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
0.2×+0.1×
PTC Therapeutics logo
PTC TherapeuticsPTCT
0.1×0.0×
Insmed logo
InsmedINSM
0.3×-0.4×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
0.0×

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Calculated from Sarepta Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s debt-to-assets?
Sarepta Therapeutics, Inc. (SRPT) reported debt-to-assets of 0.1× in Q1 2026.
How has Sarepta Therapeutics, Inc.'s debt-to-assets changed year-over-year?
Sarepta Therapeutics, Inc.'s debt-to-assets increased by 5.2% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Sarepta Therapeutics, Inc.'s debt-to-assets?
Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s debt-to-assets has grown at a 13.2% compound annual growth rate (CAGR), from 0× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.